One of the genes most significantly overexpressed in the poorest-prognosis CGS1 subtype was IGF1 (Supplementary Fig. S20), a ligand for IGF1R that is a known potential therapeutic target for many cancers [55, 56]. The gene discussed is IGF1R; the disease is cancer.